Aiforia

About:

Aiforia’s mission is to provide global access to AI-powered image analysis for medical, healthcare professionals and beyond.

Website: https://www.aiforia.com/

Twitter/X: aiforia_tech

Top Investors: European Innovation Council, PHC Holdings, Business Finland, Ascend Capital Partners, ACME Investments

Description:

Aiforia Technologies was founded as a spin-off company from the Finnish Institute for Molecular Medicine (FIMM) at the University of Helsinki in 2013 by researchers and pioneers in the field of cloud-based microscopy and pathology and experienced life science entrepreneurs. The Aiforia® Platform brings together deep learning AI and high-performance cloud computing. Aiforia assists with the increased demand for image-based diagnostics by providing efficient and scalable solutions – enabling new discoveries and clinical support with highly accurate and consistent data. Aiforia is technologically driven establishment and keeps the capability of being image agnostic thus extending its solutions to multiple fields.

Total Funding Amount:

21.2M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Helsinki, Southern Finland, Finland

Founded Date:

2013-01-01

Contact Email:

contact(AT)aiforia.com

Founders:

Johan Lundin, Kari Pitkanen, Mikael Lundin

Number of Employees:

51-100

Last Funding Date:

2021-06-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai